Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Primary central nervous system lymphoma (PCNSL) is a form of extranodal non-Hodgkin’s B-cell lymphoma limited to the CNS. The treatment of PCNSL is ineffective partly due to the blood-brain barrier (BBB) restriction of delivery of many drugs including anti-CD20 (Rituximab; RTX) which is a standard t...

Full description

Bibliographic Details
Main Authors:	Nutthanit Thumrongsiri, Paweena Dana, Rand Bawab, Prattana Tanyapanyachon, Chaichana Treetidnipa, Nattika Saengkrit, Sith Sathornsumetee
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Lymphoma CNS CD20 liposome rituximab nanoparticle
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332222003687

Similar Items

Resveratrol Loaded Liposomes Disrupt Cancer Associated Fibroblast Communications within the Tumor Microenvironment to Inhibit Colorectal Cancer Aggressiveness
by: Paweena Dana, et al.
Published: (2022-12-01)

Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy
by: Paweena Dana, et al.
Published: (2022-07-01)

Neurosurgical Management of Central Nervous System Lymphoma: Lessons Learnt from a Neuro-Oncology Multidisciplinary Team Approach
by: Maria Alexandra Velicu, et al.
Published: (2023-04-01)

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement
by: Andrew J. Sunderland, et al.
Published: (2020-01-01)

Ongoing trials in low-grade lymphoma
by: Alexander Burchardt
Published: (2011-10-01)

A case of diffuse large B-cell lymphoma with interstitial pneumonia
by: Ge Song, et al.
Published: (2023-07-01)

Fractionated Stereotactic Radiation for Central Nervous System Lymphoma: Retrospective Analysis of Initial Cases
by: Daniel G. Schep, et al.
Published: (2023-09-01)

Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
by: Marion Alcantara, et al.
Published: (2021-10-01)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy
by: Isabel Cornell, et al.
Published: (2023-07-01)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy
by: Beata Pyrzynska, et al.
Published: (2018-05-01)

Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
by: Andrea Morales-Martinez, et al.
Published: (2021-07-01)

Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review
by: Nadine Rapiti, et al.
Published: (2022-08-01)

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy
by: Fournier LL, et al.
Published: (2023-08-01)

Central Nervous System Burkitt Lymphoma in a child (A case report).
by: Hassan Mahmoodi Nesheli
Published: (2015-09-01)

Follicular Lymphoma
by: İrfan Yavaşoğlu
Published: (2015-02-01)

Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report
by: Vanshika Goyal, et al.
Published: (2022-08-01)

CD20+ cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literature
by: Amanda J. Tschetter, MD, et al.
Published: (2020-04-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report
by: Ikhwan Rinaldi, et al.
Published: (2024-03-01)

Primary large B-cell lymphoma of the central nervous system with positive NMDAR antibody: a case report
by: Xiaoling Li, et al.
Published: (2022-08-01)

Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
by: Patrij, Katrin, et al.
Published: (2011-01-01)

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
by: Naoki Wada, et al.
Published: (2009-10-01)

Development of combinatorial antibody therapies for diffuse large B cell lymphoma
by: Eric S. Geanes, et al.
Published: (2022-10-01)

Primary dural Lymphoma: A case report
by: IBRAHIM Al-hassana Idriss, et al.
Published: (2024-06-01)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
by: Ruben Van Dijck, et al.
Published: (2021-04-01)

Pretreatment diffusion-weighted imaging for prediction of relapsed and refractory primary central nervous system lymphoma
by: Hsi-Cheng Chien, et al.
Published: (2023-08-01)

Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
by: Gianpaolo Marcacci, et al.
Published: (2021-06-01)

B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma
by: Rodrigo Javier, et al.
Published: (2018-06-01)

Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
by: Khadega A. Abuelgasim, et al.
Published: (2021-01-01)

Intravascular large B cell lymphoma
by: Ricardo García-Muñoz, et al.
Published: (2014-01-01)

Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma
by: Roiya Farhan, MBBS, et al.
Published: (2020-12-01)

Primary breast lymphoma of childhood: a case report and review of literature
by: Giulia A. Restivo, et al.
Published: (2021-11-01)

The beginning of the new era of monoclonal antibodies biosimilars use in oncology:current international guidelines and the results of clinical trial of the first Russian rituximab biosimilar in patients with B-cell non-Hodgkin’s lymphoma
by: K D Kaplanov, et al.
Published: (2014-06-01)

Sarcoidosis in Close Family Members and Susceptibility to High Grade B-Cell Lymphoma: A Case Report Study
by: Hana Magrouni, et al.
Published: (2022-11-01)

Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report
by: Anna Mair, et al.
Published: (2021-09-01)

Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review)
by: K. A. Komratova, et al.
Published: (2017-04-01)

Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
by: Jinuk Kim, et al.
Published: (2021-11-01)

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
by: Narendranath Epperla, et al.
Published: (2023-11-01)

Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy
by: Nurit Horesh, et al.
Published: (2014-10-01)